Investors wary as Elanco pins hopes on new products –

Shares in the animal health care company have lost more than two-thirds of their value in the past 18 months, but Elanco says a bevy of new products in its pipeline will prove an era of strong growth is yet to come.

Related Keywords

China , Germany , New York , United States , Kelley School , Blackrock , White River , America , German , David Farber , Scott Ferguson , Tim Bettington , Eli Lilly , Jeff Simmons , Cowen Steve Scala , Andrew Brackmann , Chris Schott , David Ricks , Mickey Shuey , William Blair , Morgan Stanley , Bayer Ag , Elanco Animal Health Inc , Vanguard Group , Goldman Sachs , Cnn , Nasdaq , Bayer Animal Health , Jp Morgan , Kelley School Of Business , Zoetis Inc , Eric Learned , Elanco Animal Health , General Motors , New Jersey Based Zoetis Inc , Steve Scala , Nathan Rich , Bayer Animal , Sachem Head Capital Management , Sachem Head , Primecap Management ,